The neuronal ceroid lipofuscinoses (NCLs, Batten disease) are fatal inherited neurodegenerative diseases. Sheep affected with the CLN6 form provide a valuable model to investigate underlying disease mechanisms from preclinical stages. Excitatory neuron loss in these sheep is markedly regional, localized early reactive changes accurately predicting neuron loss and subsequent symptom development. This investigation of GABAergic interneuron loss revealed similar regional effects that correlate with symptoms.
Introduction
The neuronal ceroid lipofuscinoses (NCLs, Batten disease) are inherited neurodegenerative diseases that manifest in progressive psychomotor retardation, blindness and premature death (Goebel et al., 1999; Haltia, 2003; 2006) . Collectively they are the most common cause of progressive childhood encephalopathy (Cooper, 2003) , mutations in at least eight genes, CLN1, CLN2, CLN3, CLN5, CLN6, CLN7/MFS8, CLN8 and CLN10/CTSD, giving rise to overlapping clinical forms (www.ucl.ac.uk/ncl) formerly classified by the age of onset of symptoms.
Three of these genes, CLN1, CLN2 and CTSD, encode soluble lysosomal hydrolases (Vesa et al., 1995; Sleat et al., 1997 , Siintola et al., 2006 and CLN5 a lysosomal glycoprotein of unknown function (Holmberg et al., 2004; Sleat et al., 2005) . The other genes encode predicted transmembrane proteins of unknown function. CLN3 may code for a lysosomal membrane protein (Ezaki et al., 2003; Kyttälä et al., 2004) or a resident of pre-lysosomal vesicular transport compartments (Fossale et al., 2004) . The CLN8 protein may recycle between the endoplasmic reticulum (ER) and ER-Golgi intermediate compartments (Lonka et al., 2004) . CLN6 encodes an ER resident protein that modulates the endocytosis of exogenous proteins (Gao et al., 2002; Wheeler et al., 2002; Heine et al., 2004; Mole et al., 2004) , while CLN7 also encodes a putative membrane protein (Siintola et al., 2007) .
Severe brain atrophy and the accumulation of fluorescent lysosome-derived storage bodies in neurons and most other cells throughout the body are the pathological hallmarks of the NCLs (Goebel et al., 1999; Haltia, 2003; 2006) . Defects in CLN2, CLN3, CNL5, CLN6 and CLN8 are all associated with the abnormal specific accumulation of subunit c of mitochondrial ATP synthase in lysosome-derived storage bodies (Chen et al., 2004; Herva et al., 2000; Palmer et al., 1992 Palmer et al., , 1997 Tyynelä et al., 1997) . The pathogenic mechanisms underlying these devastating neurodegenerative diseases are poorly understood and current treatments limited to alleviating symptoms. Descriptions of human pathology are largely confined to autopsy samples that reveal little about the development of disease while recent magnetic resonance imaging studies (Peña et al., 2001; Vanhanen et al., 2004) lack the resolution to describe cellular and molecular events.
The progression of pathogenesis is more easily studied in animal models and a range of genetically engineered and spontaneously occurring mouse models are available (Mitchison et al., 2004) . Large naturally occurring animal models are particularly suited because their CNS is more like that of humans, and the development of pathology and symptoms more similar to the human diseases (Tammen et al., 2006; Frugier et al., 2008) . The South Hampshire sheep model is particularly well characterised (Jolly et al., 1989; Palmer et al., 1992; Oswald et al., 2005; Kay et al., 2006; Tammen et al., Neurobiology of Disease 32 (2008) 50-65 
